PhD, Pharmaceutical Economics and Policy
Massachusetts College of Pharmacy and Health Sciences, Boston, MA
MS, Regulatory Affairs
Northeastern University at Boston, Boston, MA
BPharm
Gujarat University, Gujarat, India
Snehal Mahida, PhD, is a Senior Associate in the Market Access and Outcomes Strategy group with RTI-HS. Dr. Mahida’s health economics and outcomes research–related experience includes performing systematic and targeted literature reviews focused on a variety of health economics and outcomes research topics including patient-reported outcomes and clinical and economic outcomes. Dr. Mahida has cost-effectiveness analysis research and writing experience from her work at the MCPHS University and from her previous work at Novartis and Axtria Inc. Dr. Mahida has presented her research at local, national, and international conferences.
In her role at RTI-HS, Dr. Mahida provides research and technical writing support for competitive landscape reviews, evidence-based dossiers, systematic and targeted literature reviews, and slide sets. She has experience in a wide variety of therapeutic areas, including oncology, rare disease, multiple sclerosis, progressive brain diseases, and cardiovascular disease.